Himalaya Nutravedics India SME IPO GMP History
Himalaya Nutravedics India SME IPO has been listed on September 29, 2026 at a listing price of ₹118, against the issue price of ₹106 — a gain of ₹12 (+11.32%). The GMP peaked at ₹0 on 29 September 2026 and reached a low of ₹0 on 29 September 2026. The day-wise GMP trend below shows how grey market sentiment evolved from subscription to listing.
Himalaya Nutravedics India SME IPO raised ₹26.5 Cr. through its IPO at a price band of ₹100 to ₹106 per share, with a lot size of 1200 shares. The IPO was open for subscription from 22 Sep 2026 to 24 Sep 2026.
Researched & reviewed by
Abhishek Vohera,
Founder, IPO Guru
Last updated
Figures sourced from the RHP, BSE & NSE
GMP trend
Grey market premium sampled three times a day (11 AM, 5 PM, 10 PM). Last updated 29 Sep, 6:30 PM IST.
Day-wise GMP
The last reading of each day, newest first. Arrows compare with the previous day.
| Date | GMP | ↑↓ | % | Kostak | Sub. Sauda |
|---|---|---|---|---|---|
| 29 Sep 2026 | ₹ 0 | — | 0% | — | — |
| 28 Sep 2026 | ₹ 0 | — | 0% | — | — |
| 27 Sep 2026 | ₹ 0 | — | 0% | — | — |
| 26 Sep 2026 | ₹ 0 | — | 0% | — | — |
| 25 Sep 2026 | ₹ 0 | — | 0% | — | — |
| 24 Sep 2026 | ₹ 0 | — | 0% | — | — |
| 23 Sep 2026 | ₹ 0 | — | 0% | — | — |
| 22 Sep 2026 | ₹ 0 | — | 0% | — | — |
| 21 Sep 2026 | ₹ 0 | — | 0% | — | — |
| 20 Sep 2026 | ₹ 0 | — | 0% | — | — |
| 19 Sep 2026 | ₹ 0 | — | 0% | — | — |
Himalaya Nutravedics India SME IPO dates
Key dates from opening to listing. Today is 9 November.
- Open 22 Sep 2026
- Close 24 Sep 2026
- Allotment 25 Sep 2026
- Refund/credit 28 Sep 2026
- Listing 29 Sep 2026
Himalaya Nutravedics India SME IPO actual listing price
How the grey market's final call compared with the listing-day open.
| Issue price | ₹106 |
|---|---|
| Listing gain / loss | +₹12 per share |
| Listing date | 29 Sep, 2026 |
| Actual listing price | ₹118 (+11.32%) |
Is Himalaya Nutravedics India SME IPO GMP reliable?
Grey market premium for Himalaya Nutravedics India SME IPO should be interpreted with caution. The GMP is an unregulated, unofficial market not governed by SEBI. Here's how to read the current signal:
- 01Subscription rate matters: A high GMP paired with strong subscription — especially QIB (Qualified Institutional Buyer) oversubscription — is a more reliable bullish signal than GMP alone. Read our in-depth analysis: GMP vs Subscription Data — Which Predicts Listing Gains Better?
- 02Timing matters: GMP in the first 1–2 days of subscription is less reliable. GMP on the final subscription day and the day before listing tends to be the most accurate predictor.
- 03Grey market is thin: For smaller IPOs, even a handful of large orders can swing the GMP significantly. Treat low-volume GMP signals with extra caution.
- 04Cross-check before acting: Review the Himalaya Nutravedics India SME IPO full review for a fundamentals-based assessment before making any grey market trades.
Himalaya Nutravedics India SME IPO Kostak rate explained
Two ways the grey market trades an IPO application before listing.
The Kostak rate for Himalaya Nutravedics India SME IPO was not available during the subscription period. Kostak is the fixed amount a grey market buyer pays for an IPO application regardless of allotment outcome.
The Subject to Sauda price was not available for this IPO. Subject to Sauda only applies if allotment is confirmed — the buyer pays a premium on top of the issue price per lot allotted.
Grey market trading is unofficial and unregulated by SEBI. Proceed with full awareness of the associated risks.
About Himalaya Nutravedics India SME IPO
Himalaya Nutravedics India Limited was started in June 2022. It is a Hyderabad based company that formulates, manufactures and markets Ayurvedic and nutraceutical products.
Its products come in several forms, including softgel capsules, tablets, medicated oils, liquid orals, hardgel capsules and protein powders. Being able to make all of these in one place is unusual for a company of this size, because each dosage form needs its own line and approvals. Its products cover therapeutic areas such as digestive health, immunity, metabolic health and pain management.
It sells in two ways. Its own branded products are marketed through healthcare practitioners rather than through mass advertising, so doctors recommending the product is what drives sales. Alongside that it manufactures on a third party contract basis for other brands. It has expanded to 17 states and one union territory in India. Its manufacturing facility is in Hyderabad, Telangana and holds ISO 22000:2018, ISO 9001:2015 and WHO-GMP certification. As on 30 April 2026 it had 80 employees.
Frequently asked
What is the GMP of Himalaya Nutravedics India SME IPO?
The current Grey Market Premium (GMP) of Himalaya Nutravedics India SME IPO is not yet started or active in the market.
What is the Kostak Price of Himalaya Nutravedics India SME IPO?
Kostak rate is the profit made by selling an IPO application before allotment. The current Kostak rate for Himalaya Nutravedics India SME IPO is not available.
What is the Subject to Sauda Price of Himalaya Nutravedics India SME IPO?
Subject to Sauda is the premium amount decided if the allotment is confirmed. The current Subject to Sauda rate is not available.
What was the actual listing price of Himalaya Nutravedics India SME IPO?
Himalaya Nutravedics India SME IPO listed on September 29, 2026 at ₹118, against the issue price of ₹106 — a gain of +11.32%.
How did the GMP of Himalaya Nutravedics India SME IPO trend before listing?
The GMP of Himalaya Nutravedics India SME IPO was stable in its final days before listing. The GMP peaked at ₹0 on 29 September 2026. View the day-wise table above for the complete GMP history.
Explore Himalaya Nutravedics India SME IPO further
The grey market is one signal. Read it alongside the demand, the reviews and the filings before you decide.
It has listed — go back to the fundamentals.
Category-wise demand from QIB, NII and retail investors, updated through the day.
What brokers and analysts are saying about this issue, in one place.
Check with your PAN whether shares were credited to your demat account.
The grey market called it. Now check the fundamentals.
IPO Guru tracks GMP, subscription and allotment for every Mainboard and SME issue. Read the grey market alongside the subscription book and the offer document before you apply.
Not investment advice. Grey market premium is an unofficial, unregulated indicator and is not a forecast.
